(Q39972441)

16 September 2017

1 reference

title

The role of amines in the etiology of schizophrenia (English)

1 reference

16 September 2017

0 references

Faurbye A

1 reference

16 September 2017

publication date

1 March 1968

1 reference

16 September 2017

published in

Comprehensive Psychiatry

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

155-177

1 reference

Schizophrenia: a new approach

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Effects of 3,4-Dimethoxyphenylethylamine in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Schizophrenia; a new approach. II. Result of a year's research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Schizophrenia: A New Approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Adrenochrome in blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Is adrenochrome present in the blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

On the measurement of adrenochrome in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

On the relationship of adrenaline and its oxidation products to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Metabolism of epinephrine and other sympathomimetic amines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

The phsiological and psychological effects of intravenously administered epinephrine, and its metabolism, in normal and schizophrenic men. III. Metabolism of 7-H3-epinephrine as determined in studies on blood and urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Isolation and Characterization of a Compound from the Urine of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

The characteristics of an amine found in urine of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Conversion of Dopamine to 3,4-Dimethoxyphenylacetic Acid in Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

3,4-Dimethoxyphenylacetic Acid in Urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Para-O-Methylation of Dopamine in Schizophrenic and Normal Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

4-methoxyphenylethylamine and 3,4-dimethoxyphenylethylamine in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

‘Pink Spot’ in the Urine of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

3,4-Dimethoxyphenylethylamine and Other Amines in the Urine of Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Excretion of 3,4-dimethoxyphenyl-ethylamine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Failure to detect 3,4-Dimethoxyphenylethylamine in the Urine of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

INVESTIGATION ON THE OCCURRENCE OF THE DOPAMINE METABOLITE 3,4-DIMETHOXYPHENYLETHYLAMINE IN THE URINE OF SCHIZOPHRENICS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Failure to detect 3,4-Dimethoxyphenylethylamine and Bufotenine in the Urine from a Case of Periodic Catatonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Does 3,4-dimethoxyphenylethylamine occur in the urine from schizophrenics and normal persons?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

3,4-Dimethoxyphenylethylamine in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

The “Pink Spot” and Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Identity of the “Pink Spot”

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Is brain damage the cause of "pink spot"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Identity of a Urinary “Pink Spot” in Schizophrenia and Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Urinary Amines in Chronic Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

A further study of catecholamine omicron-methylation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Occurrence of 3,4-Dimethoxyphenylacetic Acid in Urines of Normal and Schizophrenic Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Metabolism of Tritium Labelled Dopamine in Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Role of 3,4-Dimethoxyphenethylamine in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Acute psychosis caused by dextro-amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

The occurrence of paranoid incidents and abstinence delirium in abusers of amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

PERSISTENT HALLUCINOSIS FOLLOWING REPEATED ADMINISTRATION OF HALLUCINOGENIC DRUGS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

ADRENERGIC MECHANISMS AND AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Zur Pharmakologie des 1-Phenyl-2-methylaminopropans (Pervitin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

DOPA and other naturally occurring substances as causes of stereotypy and rage in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

ON THE RELATION OF TRYPTAMINIC AND SEROTONERGIC MECHANISMS TO AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Role of Catecholamines in the Amphetamine Excitatory Response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Evidence that the central action of amphetamine is mediated via catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Diethyldithiocarbamate and amphetamine stereotype behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Physiological effects of schizophrenic body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Serum phenylalanine in schizophrenia: biochemical genetic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Mental illness in parents of phenylketonuric children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

URINARY EXCRETION OF PHENETHYLAMINE AND TYRAMINE IN NORMAL SUBJECTS AND HETEROZYGOUS CARRIERS OF PHENYLKETONURIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

A sensitive method for the detection of n,n-dimethylserotonin (bufotenin) in urine; failure to demonstrate its presence in the urine of schizophrenic and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Search for a bufotenin-like substance in the urine of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

URINARY INDOLES IN SCHIZOPHRENIC AND PSYCHONEUROTIC PATIENTS AFTER ADMINISTRATION OF TRANYLCYPROMINE (PARNATE) AND METHIONINE OR TRYPTOPHAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

THE EFFECT OF MAO INHIBITION ON THE EXPERIMENTAL PSYCHOSIS INDUCED BY DIMETHYLTRYPTAMINE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Effects of amino acid feedings in schizophrenic patients treated with iproniazid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Effects of methionine loading on the behavior of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Effect of synthetic diet low in aromatic amino acids on schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

INVESTIGATIONS ON THE TRYPTOPHANE METABOLISM (VIA KYNURENINE) IN SCHIZOPHRENIC PATIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Urinary amines of intestinal bacterial origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Variations of Urinary Creatinine and its Correlation to Tryptamine Excretion in Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

Failure to detect 3,4-dimethoxyphenylethylamine in the urine of psychotic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2868%2980051-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-440X(68)80051-3

1 reference

16 September 2017

1 reference